Since cisplatin and gemcitabine are standard chemotherapy regimens for NPC and capable of inducing senescence,[29, 30, 31] we treated NPC cells with cisplatin or gemcitabine to induce senescence and performed beta‐galactosidase (SA‐β‐gal) staining, a standard cellular senescence marker. The gene discussed is GLB1; the disease is nasopharyngeal carcinoma.